CVS Health Corporation (CVS) Under Pressure From Medicare Proposal, Argus Holds Positive View

CVS Health Corporation (NYSE:CVS) is included among 12 Unstoppable Dividend Stocks to Buy According to Analysts. JPMorgan Names CVS a Top Pick as Turnaround Gains Traction On January 28, Argus trimmed its price recommendation on CVS Health Corporation (NYSE:CVS) to $90 from $91. However, the firm maintained a Buy rating on the stock. The shares fell nearly 15% after the Centers for Medicare and Medicaid Services proposed keeping Medicare Advantage reimbursement rates flat for 2027 compared with 2026. Arg ...